Skip to Post Results

Article Results:

[Nov 30, 2016] CVS Health, by Mark Robertson
Ken Kavula selected CVS for the November Round Table and his motion was seconded by the audience poll. This is the third selection of CVS for this feature.

[Dec 01, 2015] Tin Cup Model Portfolio, by Mark Robertson
Accumulate CVS Health

[Nov 01, 2016] Tin Cup Demonstration Portfolio, by Mark Robertson
Accumulate CVS Health (CVS)

[Mar 01, 2018] Tin Cup Demonstration Portfolio (March 2018), by Mark Robertson
After two years of advances, the Tin Cup portfolio held its own during the challenge and turbulence that was February. CVS Health is accumulated.

[Apr 01, 2018] Tin Cup Demonstration Portfolio (April 2018), by Mark Robertson
As the first down quarter in recent memory came to a close, Tin Cup stumbled ... but the Wilshire 5000 dropped even more. CVS Health is accumulated.

[Aug 01, 2018] Tin Cup Demonstration Portfolio (August 2018), by Mark Robertson
Tin Cup approaches all-time highs again. We accumulate CVS Health (CVS) and place Qualcomm (QCOM) squarely on the challenge hot seat.

[Mar 01, 2019] Tin Cup Demonstration Portfolio (March 2019), by Mark Robertson
Un-Healthy Uncertainty. The blending of CVS Health and Aetna delivers considerable turbulence during February. Shares of Booking (BKNG) are accumulated. The long term rate of return is 13.2% for Tin Cup.

[Jul 01, 2018] Tin Cup Demonstration Portfolio (July 2018), by Mark Robertson
Yet another strong month for Tin Cup, beating the Wilshire 5000 in 10-of-the-last 11 months. We accumulate CVS Health (CVS) and celebrate the near all-time high value of total assets while challenging Biogen (BIIB) after its recent surge.

[Jul 11, 2017] Tin Cup Model Portfolio, by Mark Robertson
The Tin Cup model portfolio outperformed the Wilshire 5000 during June, continuing a string of stronger performance. Cognizant Technology (CTSH) has been kind to many of our portfolios. Decisions: Accumulate CVS Health (CVS). Sell C.H. Robinson (CHRW). Buy Alliance Data Systems (ADS).

[Jun 01, 2020] Tin Cup Demonstration Portfolio (June 2020), by Mark Robertson
Following in Round Table Portfolio-Centered footsteps, CVS Health *CVS), Simulations Plus (SLP) and Alliance Data Systems (ADS) were sold. New positions started in Abbvie (ABBV) and EPAM Systems (EPAM). Shares accumulated in Air Lease (AL), Schwab (SCHW), Align Technology (ALGN), and Jazz Pharma (JAZZ).

[Oct 01, 2017] Tin Cup Model Portfolio (October 2017), by Mark Robertson
Tin Cup: Performance Update. After gaining and passing $1,700,000 a few short months ago, the portfolio topped $1,800,000 during September.

[Mar 01, 2015] Tin Cup Model Portfolio, by Mark Robertson
Reduce CVS, Buy Cognizant Tech (CTSH)

[Sep 01, 2017] Tin Cup Model Portfolio (September 2017), by Mark Robertson
Another solid month for Tin Cup as August performance outpaced the Wilshire 5000. Since inception (1994), the rate of return is 13.9% versus 7.0% for the total stock market.

[May 10, 2018] Tin Cup Demonstration Portfolio (May 2018), by Mark Robertson
Tin Cup holds above $2,000,000 and some redistribution within the portfolio boosts the overall return forecast ... trim ILMN and V, accumulate ADS and CVS.

[Mar 01, 2018] Sweet 16: Screening Results, by Mark Robertson
For the February Round Table, some went looking for oversold opportunities or companies trading close to 52-week lows ... and certainly companies with favorable long term return forecasts.

[Jun 01, 2017] Sweet 16: Our Recipe Of Quality & Returns, by Mark Robertson
The screening results this month are based on the Manifest Rank but presented in the Fave Five format. Leadership quality companies with superior long term return forecasts. Expectations for the next year are provided courtesy of the analyst consensus (ACE), S&P and Goldman Sachs.

[Jun 01, 2018] Tin Cup Demonstration Portfolio (June 2018), by Mark Robertson
Another strong month of outperformance for the Tin Cup portfolio, making it 9-of-the-last-10 months with the 10th a tie. We accumulate CVS, express our gratitude to Illumina (ILMN) and bid adieu ... and buy Amazon (AMZN).

[Nov 01, 2019] Tin Cup Demonstration Portfolio (November 2019), by Mark Robertson
Tin Cup has now regained 22.4% over the trailing 10 months ... outpacing the Wilshire 5000.

[Oct 01, 2018] Accumulate Alphabet/Google (GOOG), by Mark Robertson
The Tin Cup Model (or Demonstration) Portfolio has outperformed the Wilshire 5000 over the last month and last five years with a rate of return since inception (1995) of 14.9%.

[Jan 01, 2020] Tin Cup Demonstration Portfolio (January 2020), by Mark Robertson
Not all Decembers are created equal. Think back to the carnage from December 2018. From the stock market low on Christmas Eve 2018 ... Tin Cup has gained 37.5% since hearing the bells on that unsettling Christmas Eve. Accumulate Google (GOOG).

[Sep 01, 2008] CVS Caremark, by Mark Robertson
CVS Caremark appears to be firing on several cylinders and is worth a closer look.

[Mar 01, 2013] Quality Ranked: Excellence Measured, by Mark Robertson
Placing the quality rating into context is what really matters and what was intended by Benjamin Graham and leader of the modern investment club movement, George Nicholson.

[Mar 01, 2013] Tin Cup Model Portfolio, by Mark Robertson
Accumulate CVS Caremark

[Nov 01, 2010] Tin Cup Model Portfolio, by Mark Robertson
Accumulate CVS Caremark (CVS).

[Nov 01, 2007] Tin Cup Model Portfolio, by Mark Robertson
Accumulate CVS Caremark (CVS).

[Sep 01, 2007] Tin Cup Model Portfolio, by Mark Robertson
Accumulate CVS Caremark (CVS).

[Aug 01, 2008] Tin Cup Model Portfolio, by Mark Robertson
Accumulate CVS Caremark (CVS).

[Jul 25, 2018] MANIFEST 40 Update, by Mark Robertson
Our MANIFEST 40 is a celebration of collective excellence in stock selection, strategy and disciplined patience. The rate of return since inception (2005) is 10.1%.

[Aug 31, 2018] The Rains of Castamere?, by Mark Robertson
Better Selling. Our explorations to build selling disciplines based on the time-honored lessons of the modern investment club continues. The August Round Table featured some deployment of selling discipline that some might compare to an infamous Red Wedding. The rate of return since inception stands at 18.8% over the trailing eight years.

[Feb 12, 2018] Sweet 16: Screening Results, by Mark Robertson
The Heavy Hogs for 2017 generated an annual total return of 42.4%. Here's the consensus favorites from this year's contest.

[Sep 01, 2007] CVS Caremark, by Mark Robertson
CVS Caremark (CVS) has an enviable quality trend and a PAR that's strong despite the price advance of recent years.

[Nov 01, 2006] Walgreen, by Mark Robertson
Wal-Mart creates a disturbance in the force.

[Feb 07, 2006] Adding Prospects to NetSuite, by Mark Robertson
Features for February 2006

[Dec 01, 2017] Tin Cup Demonstration Portfolio (December 2017), by Mark Robertson
We give thanks for November gains for Tin Cup. The rate of return (since inception in 1995) is now 14.5%, and this retirement account balance is approaching $2,000,000. This month we sell Mesa Labs (MLAB) and buy Jazz Pharma (JAZZ).

[Sep 01, 2008] Tin Cup Model Portfolio, by Mark Robertson
Sell BBBY, Add CVS & GRMN, Buy Coach.

[Apr 01, 2006] Tin Cup Model Portfolio, by Mark Robertson
Sell Wendy's, Buy Wrigley & Microsoft.

[Sep 01, 2005] Tin Cup Model Portfolio, by Mark Robertson
This month's $1200 contribution will be invested in Masco Corp.

[Apr 01, 2010] Tin Cup Model Portfolio, by Mark Robertson
Sell Chipotle (CMG), Add GS and QSII.

[Sep 01, 2010] Tin Cup Model Portfolio, by Mark Robertson
Sell Goldman Sachs, Buy Cisco and Deckers.

[Dec 01, 2010] Tin Cup Model Portfolio, by Mark Robertson
Sell DECK & COH ... Buy CSCO, BRLI, MELI & CL.

[Sep 01, 2008] When Monsters are Created ..., by Mark Robertson
Has CVS painted Walgreen into a corner with limited strategic options.

[Jul 01, 2007] Sweet 16, by Mark Robertson
The highest-rated companies are Whole Foods Market, Walgreen, CVS and Zimmer.

[Aug 01, 2007] Sweet 16, by Mark Robertson
The highest-rated companies Allied Irish Banks, CVS Caremark and Oracle. .

[Sep 01, 2007] Sweet 16, by Mark Robertson
The highest-rated companies are Aeropostale, Bed Bath & Beyond, CVS Caremark and Maxim Integrated Products. .

[Aug 01, 2008] Sweet 16, by Mark Robertson
The highest-rated companies are CVS Caremark, Cisco Systems and Stryker.

[Sep 01, 2008] Sweet 16, by Mark Robertson
The highest-rated companies are Conoco Phillips, XTO Energy and CVS Caremark.

[Apr 01, 2015] MANIFEST 40 Update, by Mark Robertson
Our MANIFEST 40 is a celebration of collective excellence in stock selection, strategy and disciplined patience. We continuously monitor the 40 most-widely followed stocks by our community of subscribers at Manifest Investing.

[Dec 01, 2007] Sweet 16, by Mark Robertson
The highest-rated companies are Fastenal, Accenture and FactSet Research..

[Apr 01, 2008] Sweet 16, by Mark Robertson
The highest-rated companies are UnitedHealth Group, Buffalo Wild Wings and FactSet Research.

[Jan 01, 2009] Tin Cup Model Portfolio, by Mark Robertson
Sell CBI and GRMN, buy APACHE.

Skip to Article Results

Forum Post Results:

CVS Health (CVS) · by Mark Robertson · 09/11/2018 04:24 PM · Stocks
(via Ian Gendler, Value Line) Subscribers actively seeking investment options have plenty to choose from in this week’s issue of The Value Line...

CVS Health (CVS) · by Mark Robertson · 06/11/2019 08:30 PM · Stocks
Value Line Close CVS shares have remained relatively steady, trading in a tight range over the last few months. They remain neutrally ranked for...

CVS Health (CVS) · by Mark Robertson · 06/13/2019 06:03 PM · Stocks
3 Reasons CVS Future Looks Bright (Seeking Alpha)

CVS Health (CVS) · by Mark Robertson · 12/11/2017 10:18 AM · Stocks
The stock price has been lagging during an extended period of improving fundamentals (see EPS results and trend), a condition that can portend...

CVS Health (CVS) · by Mark Robertson · 02/07/2018 09:30 AM · Stocks
Recent commentary on CVS Health (CVS) from Oakmark fund managers (via Seeking Alpha): CVS is well positioned in a U.S. health care system that...

CVS Health (CVS) · by Mark Robertson · 06/11/2018 08:31 AM · Stocks
CVS Health (CVS) … provides broad appeal. The company operates the nation’s largest pharmacy chain, with more than 9,800 stores in 42 states....

CVS Health (CVS) · by Mark Robertson · 06/11/2018 09:00 AM · Stocks
… and the chronicle for CVS. Note the return forecast approximately four years ago (see arrow on chart) at approximately $100/share. One could make...

CVS Health (CVS) · by Mark Robertson · 12/11/2018 01:56 PM · Stocks
(An update on the Value Line perspective) One issue, in our view, that provides broad appeal is CVS Health (CVS). The company operates the nation’s...

CVS Health (CVS) · by Mark Robertson · 09/27/2017 11:45 AM · Stocks
The CVS Health analysis used during the September 2017 Round Table. CVS has now been selected seven times for the Round Table. The average cost...

CVS Health (CVS) · by Matt Spielman · 02/07/2018 10:54 AM · Stocks
I do think there is a threat to CVS, in that their “cash price” for drugs is actually quite high. I do normally fill prescriptions there, as my...

CVS Health (CVS) · by Mark Robertson · 03/13/2018 12:46 PM · Stocks
3/13/2018 — CVS Health (CVS) and Aetna (AET) report that their respective shareholders have voted overwhelmingly in favor of the proposed merger....

CVS Health (CVS) · by Mark Robertson · 03/13/2018 10:30 AM · Stocks
Equity Analysis Starting with the Value Line closing paragraph: This stock has been on the decline of late. Indeed, it has lost about 20% in value...

CVS Health (CVS) · by Mark Robertson · 05/02/2018 07:36 AM · Stocks
CVS Health (CVS) Q1 results: Revenues: $45,693M (2.6%); Services Revenues: $32,218M (3.2%); Retail/LTC Revenues: $20,432M (+5.6%). Net Income:...

CVS Health (CVS) · by Mark Robertson · 06/10/2018 10:29 AM · Stocks
“We think that CVS Health would make a fine addition to any portfolio.” — Value Line We hope so, too. CVS is a Round Table favorite and holds down...

CVS Health (CVS) · by Mark Robertson · 02/21/2019 10:31 AM · Stocks
Value Line (Supplemental Report) This is an example of Value Line’s continuous coverage between the normal reporting cycle for company reports …...

CVS Health (CVS) · by Mark Robertson · 03/14/2017 02:00 PM · Stocks
CVS Health (CVS) CVS Health is the 26th most widely-followed company by Manifest Investing subscribers.

CVS Health (CVS) · by Mark Robertson · 04/06/2017 03:14 PM · Stocks
At first glance CVS Health (CVS) looks like a very attractive stock. It has a 2.6% dividend yield. It trades at a P/E of just 15.8, which would...

CVS Health (CVS) · by Mark Robertson · 04/18/2017 12:04 PM · Stocks
CVS Health — Look Past The Negativity (Seeking Alpha)

CVS Health (CVS) · by Mark Robertson · 06/01/2017 11:42 AM · Stocks
Charles Carlson was one of the featured speakers at the NAIC National Convention during May in Cincinnati, Ohio. Charles operates the Dow Theory...

CVS Health (CVS) · by Patrick Donnelly · 06/01/2017 08:37 PM · Stocks
In all seriousness though, the profit margin trends are what is troubling for me. Actually was looking at a fresh SSG before flipping over to...

CVS Health (CVS) · by Patrick Donnelly · 06/01/2017 08:12 PM · Stocks
Almost unrelated but not ….. I love that he (Chuck) called us “SSG Jockeys” :-) Someone else that know what the theory and methodology is.

CVS Health (CVS) · by Nick A DiVirgilio · 06/02/2017 11:30 PM · Stocks
Pat: I agree. I think the SSG Quarterly Trend Graph is very useful and important. I plot Sales and PTP… both quarterly and Trailing 4 quarters. I...

CVS Health (CVS) · by Mark Robertson · 06/13/2017 09:50 AM · Stocks
There are “mixed expectations” from the rhinos regarding CVS Health — but the overall consensus remains fairly strong for this widely-followed...

CVS Health (CVS) · by Mark Robertson · 06/13/2017 10:42 AM · Stocks
… and that Value Line closing paragraph — just to show what we mean: This equity has pulled back a bit in recent months. However, the...

CVS Health (CVS) · by Jeff Traeger · 06/14/2017 02:30 PM · Stocks
Do you think Amazon would start from scratch in the pill dispensing business or might they buy one of the smaller existing players?

CVS Health (CVS) · by Mark Robertson · 06/15/2017 08:05 AM · Stocks
This article via the Motley Fool suggests a “ground up” approach …...

CVS Health (CVS) · by Mark Robertson · 10/14/2017 10:06 AM · Stocks
CVS Health (CVS) was selected as a 5-star stock by Morningstar today. The price-to-fair value is 67.7%.

CVS Health (CVS) · by Matt Spielman · 10/18/2017 12:51 PM · Stocks
Anthem announced today that it is starting its own PBM, named IngenioRx. This PBM will be serviced by CVS Health. While this means that CVS is...

CVS Health (CVS) · by Mark Robertson · 11/08/2017 09:43 AM · Stocks
Good overview of the Amazon Challenge at CVS Health (CVS): https://seekingalpha.com/article/4122107-amazons-pharmacy-licenses-threaten-cvs-health

CVS Health (CVS) · by Mark Robertson · 12/11/2017 09:29 AM · Stocks
(via Value Line) “One issue that we think offers broad appeal is CVS Health (CVS). The pharmacy giant recently agreed to buy Aetna in a transaction...

CVS Health (CVS) · by Mark Robertson · 03/19/2018 11:03 AM · Stocks
This is a pretty good discussion of the CVS Health / Aetna situation. Note that the author trudges through all kinds of things to reach the same...

CVS Health (CVS) · by Mark Robertson · 11/07/2020 06:55 AM · Stocks
Strong Earnings and a new CEO Point to a Bright Future for CVS (Morning Brew) Things that have been elevated this week: heart rates, map watching,...

CVS Health (CVS) · by Mark Robertson · 04/06/2021 04:18 PM · Stocks
There’s actually a conversation posted to the Decisions Manifest folder, see: Hold CVS?

CVS Health (CVS) · by William (Bill) Thompson · 04/09/2021 06:24 PM · Stocks
I sold both CVS and WBA last year. Purchased UNH.

CVS Health (CVS) · by Mark Robertson · 09/06/2022 12:38 PM · Stocks
Bigger picture: The transaction will add 10,000 contracted doctors and clinicians and give CVS (CVS) a hand in coordinating medical care for...

CVS Health (CVS) · by Mark Robertson · 09/06/2022 08:36 AM · Stocks
CVS To Buy Signify Health (CNBC)

CVS Health (CVS) · by Mark Robertson · 01/18/2023 07:16 PM · Stocks
Equity Analysis (CVS)

CVS Health (CVS) · by Mark Robertson · 01/18/2023 07:16 PM · Stocks
Value Line Close (1/20/2023) The issue seems a safe long-term holding. Total return potential to 2025-2027 looks to be worthwhile on a...

CVS Health (CVS) · by George Blank · 01/18/2023 09:54 PM · Stocks
From ‘Simply Wall St.’ CVS Health Corporation Announces Quarterly Dividend, Payable on February 1, 2023 CVS Health Corporation has announced that...

CVS Health (CVS) · by Mark Robertson · 01/19/2023 06:56 AM · Stocks
Has CVS Come Out “The Other Side?” You may recall when the discussion on CVS revolved around an apparent shift in business strategy — embedding...

CVS Health (CVS) · by Mark Robertson · 01/19/2023 07:17 AM · Stocks
“What If?” We’d Just Held On? The $10,560 we netted from the “realized” sell transactions would now be worth an “un-realized” $18,901.

CVS Health (CVS) · by Mark Robertson · 02/10/2023 02:27 PM · Stocks
CVS Health, a leading pharmacy concern, has entered into a definitive agreement to acquire Oak Street Health (NYSE: OSH) in an all-cash transaction...

CVS Health (CVS) · by Mark Robertson · 04/20/2023 07:08 PM · Stocks
Equity Analysis (CVS)

CVS Health (CVS) · by Mark Robertson · 04/20/2023 07:07 PM · Stocks
Value Line Close (4/21/2023) CVS shares may appeal to risk-averse income-seekers. Recent price weakness has lifted long-term upside prospects,...

CVS Health (CVS) · by Mark Robertson · 07/15/2023 12:03 PM · Stocks
Equity Analysis (CVS) Cy Lynch suggested that “this is not your grandfather’s CVS” highlighting the structural changes and business strategy shifts...

CVS Health (CVS) · by Mark Robertson · 10/15/2023 01:00 PM · Stocks
Equity Analysis (CVS) Value Line Close (10/20/2023) CVS stock is timely. Too, income oriented investors may like its current above-average dividend...

CVS Health (CVS) · by Mark Robertson · 01/13/2024 11:48 AM · Stocks
Equity Analysis (CVS) Value Line Close (1/19/2024) CVS stock is ranked Highest (1) for Timeliness. Too, income-oriented investors may like its...

CVS Health (CVS) · by Mark Robertson · 04/15/2024 04:22 PM · Stocks
Equity Analysis (CVS) Value Line Open & Close The Street appears to be focusing, not so much on CVS’s prospects this year as on those of 2025....

CVS Health (CVS) · by Anne Manning · 04/24/2024 11:24 AM · Stocks
I need help understanding what is going on with CVS. I have owned it since 2017 and the price has been less than exciting. The only money I have...

CVS Health (CVS) · by Mark Robertson · 08/24/2024 12:21 PM · Stocks
Equity Analysis (CVS) Value Line Close (8/30/2024) Management is focused on turning the company around. It replaced the president of its Health...